A Randomized,Open-label,Six-sequence,Three-period,Three-treatment,Multiple Dosing Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Pregabalin and Thioctic Acid After Oral Administration in Healthy Male Volunteers
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Pregabalin; Thioctic acid
- Indications Anxiety disorders; Epilepsy; Fibromyalgia; Neuropathic pain; Postherpetic neuralgia
- Focus Pharmacokinetics
- 22 Aug 2013 Biomarkers information updated
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Mar 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea: KCT0000689).